Health ❯ Healthcare ❯ Neurology

Alzheimer's Disease

Cognitive Decline Biomarkers Treatment Options Lecanemab Diagnosis Early Detection Drug Development Risk Factors Symptoms Agitation

38 ARTICLES

last mo.

Early Detection and New Drugs Shift Alzheimer Fight as Systems Struggle to Keep Up

Blood biomarkers and disease‑slowing antibodies open a window for earlier action with unfunded national plans and limited infusion capacity threatening broad access.

25 ARTICLES

3mo ago

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

4 ARTICLES

3mo ago

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

6 ARTICLES

3mo ago

Global Analysis Finds Dementia Risk Factors Vary by Country but Cluster Similarly

5 ARTICLES

4mo ago

BCG Vaccine Reprograms Brain Immune Cells and Shifts Alzheimer’s Biomarkers

4 ARTICLES

4mo ago

Eli Lilly Licenses AlzeCure’s Preclinical Alzheimer’s Candidate

16 ARTICLES

5mo ago

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

4 ARTICLES

5mo ago

Physics-Informed AI Maps Brain-Wide Glymphatic Flow

9 ARTICLES

5mo ago

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

8 ARTICLES

6mo ago

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

7 ARTICLES

7mo ago

Blood Studies Point to Complementary Alzheimer’s Biomarkers for Prediction and Staging

4 ARTICLES

8mo ago

Noninvasive Brain Blood-Flow Markers Align With Alzheimer’s Imaging Signs

5 ARTICLES

8mo ago

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

5 ARTICLES

8mo ago

FDA Grants Priority Review to Axsome’s AXS-05 for Alzheimer’s Agitation, Sets April 30 PDUFA Date

4 ARTICLES

11mo ago

Chris Hemsworth’s Alzheimer’s Documentary Debuts on National Geographic and Disney+

Alzheimer's Disease

Early Detection and New Drugs Shift Alzheimer Fight as Systems Struggle to Keep Up

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

Global Analysis Finds Dementia Risk Factors Vary by Country but Cluster Similarly

BCG Vaccine Reprograms Brain Immune Cells and Shifts Alzheimer’s Biomarkers

Eli Lilly Licenses AlzeCure’s Preclinical Alzheimer’s Candidate

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

Physics-Informed AI Maps Brain-Wide Glymphatic Flow

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

Never miss stories about

Alzheimer's Disease

Blood Studies Point to Complementary Alzheimer’s Biomarkers for Prediction and Staging

Noninvasive Brain Blood-Flow Markers Align With Alzheimer’s Imaging Signs

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

Early Alzheimer’s Markers Identified in Peripheral Retina in Mouse Study

Blood ‘Clock’ Predicts Alzheimer’s Symptom Onset Within 3–4 Years

G-BA Finds No Added Benefit for Alzheimer’s Drug Leqembi in Germany

Biogen Guides 2026 Profit Above Estimates on Cost Cuts and Leqembi Momentum

Brazil Authorizes Leqembi for Early-Stage Alzheimer’s Treatment

FDA Grants Priority Review to Axsome’s AXS-05 for Alzheimer’s Agitation, Sets April 30 PDUFA Date

Chris Hemsworth’s Alzheimer’s Documentary Debuts on National Geographic and Disney+

Never miss stories about

Alzheimer's Disease